POTELIGEO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
42747-761 -
Package NDC
42747-761-01 -
Application number
BLA761051 -
SPL ID
1f51b7aa-6109-469c-b237-edfc3ee7b2b5 -
SPL set ID
e53960ab-42a1-40d1-9c7d-eb013fe7f18f -
UNII
YI437801BE -
RxCUI
2054081 -
RxCUI
2054086
What the source publishes
- Labeler
- Kyowa Kirin, Inc.
- Active ingredients
- mogamulizumab-kpkc
- Form
- INJECTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "POTELIGEO",
"splId": "1f51b7aa-6109-469c-b237-edfc3ee7b2b5",
"labels": [
{
"setId": "e53960ab-42a1-40d1-9c7d-eb013fe7f18f",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e53960ab-42a1-40d1-9c7d-eb013fe7f18f",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e53960ab-42a1-40d1-9c7d-eb013fe7f18f"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Kyowa Kirin, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, GLASS in 1 CARTON (42747-761-01) / 5 mL in 1 VIAL, GLASS",
"package_ndc": "42747-761-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20180808"
}
],
"productId": "42747-761_1f51b7aa-6109-469c-b237-edfc3ee7b2b5",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "42747-761",
"deaSchedule": null,
"genericName": "mogamulizumab-kpkc",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MOGAMULIZUMAB",
"strength": "4 mg/mL"
}
],
"applicationNumber": "BLA761051",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20180808",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000193866",
"N0000193863",
"N0000193867",
"M0001357"
],
"unii": [
"YI437801BE"
],
"rxcui": [
"2054081",
"2054086"
],
"spl_set_id": [
"e53960ab-42a1-40d1-9c7d-eb013fe7f18f"
],
"pharm_class_cs": [
"Antibodies, Monoclonal [CS]"
],
"pharm_class_epc": [
"Chemokine Receptor Type 4 Interaction [EPC]",
"Monoclonal Antibody [EPC]"
],
"pharm_class_moa": [
"Chemokine Receptor Type 4 Interactions [MoA]"
],
"manufacturer_name": [
"Kyowa Kirin, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:42747-761_1f51b7aa-6109-469c-b237-edfc3ee7b2b5"